Health
Rare cancer drug to be subsidised – The Transcontinental
A drug to treat a rare stomach and bowel cancer will be subsidised after being listed on the Pharmaceutical Benefits Scheme….
A drug to treat a rare stomach and bowel cancer will be subsidised after being listed on the Pharmaceutical Benefits Scheme.
People suffering from advanced gastrointestinal stromal tumour will be able to buy the drug Qinlock for at most $41.30 per script…
Continue Reading
-
General21 hours agoFour charged over alleged six-hour gang rape of girl in south-west Sydney
-
Business12 hours ago3 of the best ASX stocks to buy now with $2,500
-
Noosa News24 hours agoLogan City Council to pull out of federal government Climate Active program due to financial pressure, transparency concerns
-
General20 hours agoCarrie Bickmore pays tribute to Isaac Smith and Scott Selwood after gruelling marathon